Related Experiment Video
Updated: Jul 6, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
CPEB2 inhibit cell proliferation through upregulating p21 mRNA stability in glioma
Guang Zhao1,2,3,4,5, Zhongjun Zhao1,2,3, Mingyi Xia1,2,3
1Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.
Abstract:
Glioma is the most common primary malignant brain tumor in adults and remains an incurable disease at present. Thus, there is an urgent need for progress in finding novel molecular mechanisms that control the progression of glioma which could be used as therapeutic targets for glioma patients. The RNA binding protein cytoplasmic polyadenylate element-binding protein 2 (CPEB2) is involved in the pathogenesis of several tumors. However, the role of CPEB2 in glioma progression is unknown. In this study, the functional characterization of the role and molecular mechanism of CPEB2 in glioma were examined using a series of biological and cellular approaches in vitro and in vivo. Our work shows CPEB2 is significantly downregulated in various glioma patient cohorts. Functional characterization of CPEB2 by overexpression and knockdown revealed that it inhibits glioma cell proliferation and promotes apoptosis. CPEB2 exerts an anti-tumor effect by increasing p21 mRNA stability and inducing G1 cell cycle arrest in glioma. Overall, this work stands as the first report of CPEB2 downregulation and involvement in glioma pathogenesis, and identifies CPEB2 as an important tumor suppressor gene through targeting p21 in glioma, which revealed that CPEB2 may become a promising predictive biomarker for prognosis in glioma patients.
Insights
Cytoplasmic polyadenylate element-binding protein 2 (CPEB2) is downregulated in glioma, acting as a tumor suppressor. Its restoration inhibits glioma cell proliferation and promotes apoptosis by targeting p21, suggesting prognostic potential.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glioma is a common, incurable adult brain tumor requiring novel therapeutic targets.
- The role of RNA-binding protein cytoplasmic polyadenylate element-binding protein 2 (CPEB2) in glioma pathogenesis is currently unknown.
Purpose of the Study:
- To investigate the role and molecular mechanism of CPEB2 in glioma progression.
- To determine if CPEB2 functions as a tumor suppressor in glioma.
Main Methods:
- In vitro and in vivo biological and cellular approaches.
- Overexpression and knockdown of CPEB2 in glioma cells.
- Analysis of p21 mRNA stability and cell cycle progression.
Main Results:
- CPEB2 is significantly downregulated in glioma patient cohorts.
- CPEB2 overexpression inhibits glioma cell proliferation and promotes apoptosis.
- CPEB2 increases p21 mRNA stability, inducing G1 cell cycle arrest.
Conclusions:
- CPEB2 acts as a tumor suppressor gene in glioma by targeting p21.
- Downregulation of CPEB2 is implicated in glioma pathogenesis.
- CPEB2 may serve as a predictive biomarker for glioma prognosis.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
07:26Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Inhibition of Cdk Activity
Cell Specific Gene Expression
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...